These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10480157)

  • 1. [Pharmacological effects of the gastroprokinetic agent mosapride citrate].
    Yoshida N
    Nihon Yakurigaku Zasshi; 1999 May; 113(5):299-307. PubMed ID: 10480157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro.
    Mine Y; Yoshikawa T; Oku S; Nagai R; Yoshida N; Hosoki K
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1000-8. PubMed ID: 9399969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride.
    Matsunaga Y; Tanaka T; Yoshinaga K; Ueki S; Hori Y; Eta R; Kawabata Y; Yoshii K; Yoshida K; Matsumura T; Furuta S; Takei M; Tack J; Itoh Z
    J Pharmacol Exp Ther; 2011 Mar; 336(3):791-800. PubMed ID: 21123674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.
    Yoshida N; Omoya H; Oka M; Furukawa K; Ito T; Karasawa T
    Arch Int Pharmacodyn Ther; 1989; 300():51-67. PubMed ID: 2533479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum.
    Yoshikawa T; Yoshida N; Mine Y; Hosoki K
    Jpn J Pharmacol; 1998 May; 77(1):53-9. PubMed ID: 9639060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of mosapride citrate, a 5-HT4 receptor agonist, on colonic motility in conscious guinea pigs.
    Inui A; Yoshikawa T; Nagai R; Yoshida N; Ito T
    Jpn J Pharmacol; 2002 Dec; 90(4):313-20. PubMed ID: 12501007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mosapride citrate, a 5-HT4-receptor agonist, on gastric distension-induced visceromotor response in conscious rats.
    Seto Y; Yoshida N; Kaneko H
    J Pharmacol Sci; 2011; 116(1):47-53. PubMed ID: 21521930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation into the effects of mosapride on motility of Guinea pig stomach, ileum, and colon.
    Ji SW; Park HJ; Cho JS; Lim JH; Lee SI
    Yonsei Med J; 2003 Aug; 44(4):653-64. PubMed ID: 12950122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles.
    Kii Y; Ito T
    J Cardiovasc Pharmacol; 1997 May; 29(5):670-5. PubMed ID: 9213211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDR-5169, a new gastrointestinal prokinetic agent, enhances gastric contractile and emptying activities in dogs and rats.
    Tazawa S; Masuda N; Koizumi T; Kitazawa M; Nakane T; Miyata H
    Eur J Pharmacol; 2002 Jan; 434(3):169-76. PubMed ID: 11779580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory action of itopride hydrochloride on colonic motor activity in vitro and in vivo.
    Tsubouchi T; Saito T; Mizutani F; Yamauchi T; Iwanaga Y
    J Pharmacol Exp Ther; 2003 Aug; 306(2):787-93. PubMed ID: 12724347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prokinetic effect of the 5-HT4R agonist mosapride on canine gastric motility.
    Tsukamoto A; Ohno K; Maeda S; Nakashima K; Fukushima K; Fujino Y; Tsujimoto H
    J Vet Med Sci; 2011 Dec; 73(12):1635-7. PubMed ID: 21785238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility.
    Okamura K; Sasaki N; Yamada M; Yamada H; Inokuma H
    Res Vet Sci; 2009 Apr; 86(2):302-8. PubMed ID: 18723200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
    Yoshida N; Ito T; Karasawa T; Itoh Z
    J Pharmacol Exp Ther; 1991 May; 257(2):781-7. PubMed ID: 2033519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs.
    Kojima Y; Nakagawa T; Katsui R; Fujii H; Nakajima Y; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G351-60. PubMed ID: 15817810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study.
    Kusunoki H; Haruma K; Hata J; Kamada T; Ishii M; Yamashita N; Inoue K; Imamura H; Manabe N; Shiotani A
    J Gastroenterol; 2010 Dec; 45(12):1228-34. PubMed ID: 20658155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.
    Kii Y; Nakatsuji K; Nose I; Yabuuchi M; Mizuki Y; Ito T
    Pharmacol Toxicol; 2001 Aug; 89(2):96-103. PubMed ID: 11555327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SC-49518 enhances gastric emptying of solid and liquid meals and stimulates gastrointestinal motility in dogs by a 5-hydroxytryptamine4 receptor mechanism.
    Gullikson GW; Virina MA; Loeffler RF; Yang DC; Goldstin B; Wang SX; Moummi C; Flynn DL; Zabrowski DL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):240-8. PubMed ID: 8380862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.